People who received the recombinant shingles vaccine were 35% less likely to develop shingles over six years than those who received the older live vaccine, and this benefit was equally strong in men...
Evidence from Studies
No evidence studies found yet.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.